Cargando…
Lipoprotein(a)—clinical aspects and future challenges
Lipoprotein(a) (Lp(a)) was first described by K. Berg and is known for more than 50 years. It is an interesting particle and combines the atherogenic properties of low-density lipoprotein (LDL)-cholesterol as well as the thrombogenic properties of plasminogen inactivation. However, due to technical...
Autores principales: | Kurt, Bilgen, Soufi, Muhidien, Sattler, Alexander, Schaefer, Juergen R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361767/ https://www.ncbi.nlm.nih.gov/pubmed/25732622 http://dx.doi.org/10.1007/s11789-015-0075-z |
Ejemplares similares
-
Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FH(Marburg) (FH p.W556R)
por: Schaefer, Juergen R., et al.
Publicado: (2012) -
Fast and Easy Nanopore Sequencing Workflow for Rapid Genetic Testing of Familial Hypercholesterolemia
por: Soufi, Muhidien, et al.
Publicado: (2022) -
Increased KCNJ18 promoter activity as a mechanism in atypical normokalemic periodic paralysis
por: Soufi, Muhidien, et al.
Publicado: (2018) -
Monocytes of patients with familial hypercholesterolemia show alterations in cholesterol metabolism
por: Mosig, Sandy, et al.
Publicado: (2008) -
Molecular, Population, and Clinical Aspects of Lipoprotein(a): A Bridge Too Far?
por: Ward, Natalie C., et al.
Publicado: (2019)